TLR9 pathway is involved in adjuvant effects of plasmid DNA-based vaccines (Q38331978)

2 September 2017

TLR9 pathway is involved in adjuvant effects of plasmid DNA-based vaccines (English)

1 reference

2 September 2017

0 references

Daniela Tudor

1

1 reference

2 September 2017

Catherine Dubuquoy

2

1 reference

2 September 2017

Valérie Gaboriau

3

1 reference

2 September 2017

François Lefèvre

4

1 reference

2 September 2017

Bernard Charley

5

1 reference

2 September 2017

Sabine Riffault

6

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

2 September 2017

1 reference

2 September 2017

23

1 reference

2 September 2017

10

1 reference

2 September 2017

1258-1264

1 reference

Nucleic acid vaccines: research tool or commercial reality

2 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.001

Gene vaccination: plasmid DNA is more than just a blueprint

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.001

The role of CpG motifs in innate immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.001

Immunostimulatory DNA sequences necessary for effective intradermal gene immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.001

Bacterial CpG-DNA triggers activation and maturation of human CD11c-, CD123+ dendritic cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.001

Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.001

CpG motifs in bacterial DNA trigger direct B-cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.001

Immune effects and mechanisms of action of CpG motifs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.001

Innate immune recognition: mechanisms and pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.001

Innate immune recognition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.001

Recognition of pathogen-associated molecular patterns by TLR family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.001

A Toll-like receptor recognizes bacterial DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.001

Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.001

Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.001

Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.001

Toll-like receptors as adjuvant receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.001

Regulation of dendritic cell function through Toll-like receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.001

Controlling the Toll road to dendritic cell polarization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.001

CpG motifs: the active ingredient in bacterial extracts?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.001

Immunology. A Toll for DNA vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.001

Immunobiology of pseudorabies (Aujeszky's disease)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.001

Enhanced protective response and immuno-adjuvant effects of porcine GM-CSF on DNA vaccination of pigs against Aujeszky's disease virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.001

Induction of porcine cytokine mRNA expression after DNA immunization and pseudorabies virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.001

DNA vaccination of neonate piglets in the face of maternal immunity induces humoral memory and protection against a virulent pseudorabies virus challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.001

The preferential induction of a Th1 immune response by DNA-based immunization is mediated by the immunostimulatory effect of plasmid DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.001

Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.001

Type I IFN modulates the immune response induced by DNA vaccination to pseudorabies virus glycoprotein C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.001

The plasmid pcDNA3 differentially induces production of interferon-alpha and interleukin-6 in cultures of porcine leukocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.001

Herpes simplex virus induces appearance of interferon-alpha/beta-producing cells and partially interferon-alpha/beta-dependent accumulation of leukocytes in murine regional lymph nodes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.001

CpG DNA redirects class-switching towards "Th1-like" Ig isotype production via TLR9 and MyD88.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.001

Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.001

Vaccination with plasmid DNA activates dendritic cells via Toll-like receptor 9 (TLR9) but functions in TLR9-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.001

Immunostimulatory effects of plasmid DNA and synthetic oligodeoxynucleotides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.001

Recognition of single-stranded RNA viruses by Toll-like receptor 7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.001

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.001

Co-immunization with plasmid IL-12 generates a strong T-cell memory response in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.001

Links between innate and adaptive immunity via type I interferon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.001

10.1016/J.VACCINE.2004.09.001

7 January 2021

Identifiers

DOI

1 reference

2 September 2017

1 reference